Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Children must be protected from the tobacco industry's marketing tactics.

Hopkinson N, Wallis C, Higgins B, Gaduzo S, Sherrington R, Keilty S, Stern M, Britton J, Bush A, Moxham J, Sylvester K, Griffiths V, Sutherland T, Crossingham I, Raju R, Spencer C, Safavi S, Deegan P, Seymour J, Hickman K, Hughes J, Wieboldt J, Shaheen F, Peedell C, Mackenzie N, Nicholl D, Jolley C, Crooks G, Crooks G, Dow C, Deveson P, Bintcliffe O, Gray B, Kumar S, Haney S, Docherty M, Thomas A, Chua F, Dwarakanath A, Summers G, Prowse K, Lytton S, Ong YE, Graves J, Banerjee T, English P, Leonard A, Brunet M, Chaudhry N, Ketchell RI, Cummings N, Lebus J, Sharp C, Meadows C, Harle A, Stewart T, Parry D, Templeton-Wright S, Moore-Gillon J, Stratford- Martin J, Saini S, Matusiewicz S, Merritt S, Dowson L, Satkunam K, Hodgson L, Suh ES, Durrington H, Browne E, Walters N, Steier J, Barry S, Griffiths M, Hart N, Nikolic M, Berry M, Thomas A, Miller J, McNicholl D, Marsden P, Warwick G, Barr L, Adeboyeku D, Mohd Noh MS, Griffiths P, Davies L, Quint J, Lyall R, Shribman J, Collins A, Goldman J, Bloch S, Gill A, Man W, Christopher A, Yasso R, Rajhan A, Shrikrishna D, Moore C, Absalom G, Booton R, Fowler RW, Mackinlay C, Sapey E, Lock S, Walker P, Jha A, Satia I, Bradley B, Mustfa N, Haqqee R, Thomas M, Patel A, Redington A, Pillai A, Keaney N, Fowler S, Lowe L, Brennan A, Morrison D, Murray C, Hankinson J, Dutta P, Maddocks M, Pengo M, Curtis K, Rafferty G, Hutchinson J, Whitfield R, Turner S, Breen R, Naveed SU, Goode C, Esterbrook G, Ahmed L, Walker W, Ford D, Connett G, Davidson P, Elston W, Stanton A, Morgan D, Myerson J, Maxwell D, Harrris A, Parmar S, Houghton C, Winter R, Puthucheary Z, Thomson F, Sturney S, Harvey J, Haslam PL, Patel I, Jennings D, Range S, Mallia-Milanes B, Collett A, Tate P, Russell R, Feary J, O'Driscoll R, Eaden J, Round J, Sharkey E, Montgomery M, Vaughan S, Scheele K, Lithgow A, Partridge S, Chavasse R, Restrick L, Agrawal S, Abdallah S, Lacy-Colson A, Adams N, Mitchell S, Haja Mydin H, Ward A, Denniston S, Steel M, Ghosh D, Connellan S, Rigge L, Williams R, Grove A, Anwar S, Dobson L, Hosker H, Stableforth D, Greening N, Howell T, Casswell G, Davies S, Tunnicliffe G, Mitchelmore P, Phitidis E, Robinson L, Prowse K, Bafadhel M, Robinson G, Boland A, Lipman M, Bourke S, Kaul S, Cowie C, Forrest I, Starren E, Burke H, Furness J, Bhowmik A, Everett C, Seaton D, Holmes S, Doe S, Parker S, Graham A, Paterson I, Maqsood U, Ohri C, Iles P, Kemp S, Iftikhar A, Carlin C, Fletcher T, Emerson P, Beasley V, Ramsay M, Buttery R, Mungall S, Crooks S, Ridyard J, Ross D, Guadagno A, Holden E, Coutts I, Cullen K, O'Connor S, Barker J, Sloper K, Watson J, Smith P, Anderson P, Brown L, Nyman C, Milburn H, Clive A, Serlin M, Bolton C, Fuld J, Powell H, Dayer M, Woolhouse I, Georgiadi A, Leonard H, Dodd J, Campbell I, Ruiz G, Zurek A, Paton JY, Malin A, Wood F, Hynes G, Connell D, Spencer D, Brown S, Smith D, Cooper D, O'Kane C, Hicks A, Creagh-Brown B, Lordan J, Nickol A, Primhak R, Fleming L, Powrie D, Brown J, Zoumot Z, Elkin S, Szram J, Scaffardi A, Marshall R, Macdonald I, Lightbody D, Farmer R, Wheatley I, Radnan P, Lane I, Booth A, Tilbrook S, Capstick T, Hewitt L, McHugh M, Nelson C, Wilson P, Padmanaban V, White J, Davison J, O'Callaghan U, Hodson M, Edwards J, Campbell C, Ward S, Wooler E, Ringrose E, Bridges D, Matthew Hodson, John Edwards, Colin Campbell, Simon Ward, Edwina Wooler, Elizabeth Ringrose, Diana Bridges, Rosalind Backham, Kim Randall, Tracey Mathieson, Long A, Parkes M, Clarke S, Allen B, Connelly C, Forster G, Hoadley J, Martin K, Barnham K, Khan K, Munday M, Edwards C, O'Hara D, Turner S, Pieri-Davies S, Ford K, Daniels T, Wright J, Towns R, Fern K, Butcher J, Burgin K, Winter B, Freeman D, Olive S, Gray L, Pye K, Roots D, Cox N, Davies CA, Wicker J, Hilton K, Lloyd J, MacBean V, Wood M, Kowal J, Downs J, Ryan H, Guyatt F, Nicoll D, Lyons E, Narasimhan D, Rodman A, Walmsley S, Newey A, Buxton M, Dewar M, Cooper A, Reilly J, Lloyd J, Macmillan AB, Roots D, Olley A, Voase N, Martin S, McCarvill I, Christensen A, Agate R, Heslop K, Timlett A, Hailes K, Davey C, Pawulska B, Lane A, Ioakim S, Hough A, Treharne J, Jones H, Winter-Burke A, Miller L, Connolly B, Bingham L, Fraser U, Bott J, Johnston C, Graham A, Curry D, Sumner H, Costello CA, Bartoszewicz C, Badman R, Williamson K, Taylor A, Purcell H, Barnett E, Molloy A, Crawfurd L, Collins N, Monaghan V, Mir M, Lord V, Stocks J, Edwards A, Greenhalgh T, Lenney W, McKee M, McAuley D, Majeed A, Cookson J, Baker E, Janes S, Wedzicha W, Lomas Dean D, Harrison B, Davison T, Calverley P, Wilson R, Stockley R, Ayres J, Gibson J, Simpson J, Burge S, Warner J, Lenney W, Thomson N, Davies P, Woodcock A, Woodhead M, Spiro S, Ormerod L, Bothamley G, Partridge M, Shields M, Montgomery H, Simonds A, Barnes P, Durham S, Malone S, Arabnia G, Olivier S, Gardiner K, Edwards S.

BMJ. 2013 Dec 9;347:f7358. doi: 10.1136/bmj.f7358. No abstract available.

2.

The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.

Nikander K, Denyer J, Dodd M, Dyche T, Webb K, Weller P, Stableforth D.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S21-7. doi: 10.1089/jamp.2009.0770.

3.

Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.

Mulheran M, Hyman-Taylor P, Tan KH, Lewis S, Stableforth D, Knox A, Smyth A.

Antimicrob Agents Chemother. 2006 Jul;50(7):2293-9.

4.

Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis.

Chambers D, Scott F, Bangur R, Davies R, Lim A, Walters S, Smith G, Pitt T, Stableforth D, Honeybourne D.

Eur Respir J. 2005 Oct;26(4):651-6.

5.

Tobramycin dosing in cystic fibrosis.

Smyth A, Touw D, Tan KH, Bertenshaw C, Stableforth D.

Lancet. 2005 May 21-27;365(9473):1767-8. No abstract available.

PMID:
15910946
6.

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.

Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A; TOPIC Study Group.

Lancet. 2005 Feb 12-18;365(9459):573-8.

PMID:
15708100
7.

Sites of implantation for central venous access devices (ports): a study of the experiences and preferences of patients.

Campbell WB, Elworthy S, Peerlinck I, Vanslembroek K, Bangur R, Stableforth D, Sheldon CD.

Eur J Vasc Endovasc Surg. 2004 Dec;28(6):642-4.

8.

Bilateral fractured neck of the femur in an adult patient with cystic fibrosis.

Lim AY, Isopescu S, Thickett KM, Gumery LB, Darby AJ, Honeybourne D, Stableforth DE.

Eur J Intern Med. 2003 May;14(3):196-198.

PMID:
12798220
9.

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin.

Lim AY, Parr DG, Stableforth DE, Fellows M, Fontaine R, Fegan CD.

Eur J Intern Med. 2003 Mar;14(2):89-93.

PMID:
12719024
10.

Exhaled nitric oxide in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.

Lim AY, Chambers DC, Ayres JG, Stableforth DE, Honeybourne D.

Respir Med. 2003 Apr;97(4):331-6.

12.

Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings.

Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE.

QJM. 2002 Oct;95(10):655-62. Review.

PMID:
12324637
13.

Transplantation for cystic fibrosis: outcome following early liver transplantation.

Milkiewicz P, Skiba G, Kelly D, Weller P, Bonser R, Gur U, Mirza D, Buckels J, Stableforth D, Elias E.

J Gastroenterol Hepatol. 2002 Feb;17(2):208-13.

PMID:
11966953
14.

Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.

Mulheran M, Degg C, Burr S, Morgan DW, Stableforth DE.

Antimicrob Agents Chemother. 2001 Sep;45(9):2502-9.

15.

Awareness of infertility in men with cystic fibrosis.

Thickett KM, Stableforth DE, Davies RE, Smith E, Edenborough FP.

Fertil Steril. 2001 Aug;76(2):407-8. No abstract available.

PMID:
11476799
16.

A political asylum seeker with an amoebic empyema in Birmingham.

Banerjee D, Clamp A, Stableforth D.

Hosp Med. 2001 Jun;62(6):372-3. No abstract available.

PMID:
11436450
17.

A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.

Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.

Respiration. 2001;68(2):160-4.

PMID:
11287830
18.

The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Banerjee D, Stableforth D.

Drugs. 2000 Nov;60(5):1053-64. Review.

PMID:
11129122
19.

Extrapleural bronchial artery ligation for life-threatening hemoptysis in cystic fibrosis--a case report.

Kaukuntla HK, Amer KM, Honeybourne D, Stableforth DE, Khalil-Marzouk JF.

Angiology. 2000 Sep;51(9):787-92.

PMID:
10999621
20.

A prospective study of nasal disease in adult cystic fibrosis.

Raj P, Stableforth DE, Morgan DW.

J Laryngol Otol. 2000 Apr;114(4):260-3.

PMID:
10845039
21.

The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977-1996.

Edenborough FP, Mackenzie WE, Stableforth DE.

BJOG. 2000 Feb;107(2):254-61.

22.

Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis.

Thickett KM, Wildman MJ, Fegan CD, Stableforth DE.

J Antimicrob Chemother. 1999 Mar;43(3):435-6. No abstract available.

PMID:
10223610
23.

Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults.

Smith DL, Smith EG, Pitt TL, Stableforth DE.

J Infect. 1998 Jul;37(1):41-3.

PMID:
9733377
24.
25.
26.
27.

The failing health care system for adult patients with cystic fibrosis.

Conway SP, Stableforth DE, Webb AK.

Thorax. 1998 Jan;53(1):3-4. No abstract available.

28.

Serum IgG response to an outer membrane porin protein of Burkholderia cepacia in patients with cystic fibrosis.

Lacy DE, Smith AW, Lambert PA, Peckham D, Stableforth DE, Smith EG, Desai M, Weller PH, Brown MR.

FEMS Immunol Med Microbiol. 1997 Feb;17(2):87-94.

29.

Distinction between pleural mesothelioma and pulmonary adenocarcinoma using MOC31 in an asbestos sprayer.

Ryan PJ, Oates JL, Crocker J, Stableforth DE.

Respir Med. 1997 Jan;91(1):57-60.

30.

Severe lipoid pneumonia following attempted suicide by mineral oil immersion.

Hussain IR, Edenborough FP, Wilson RS, Stableforth DE.

Thorax. 1996 Jun;51(6):652-3; discussion 656-7.

31.

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.

Muhdi K, Edenborough FP, Gumery L, O'Hickey S, Smith EG, Smith DL, Stableforth DE.

Thorax. 1996 Apr;51(4):374-7.

33.

Pregnancy in women with cystic fibrosis.

Edenborough FP, Stableforth DE, Mackenzie WE.

BMJ. 1995 Sep 30;311(7009):822-3. No abstract available.

34.
35.

Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment.

Bush A, Hodson ME, Geddes DM, Rosenthal M, Dinwiddie R, Wallis C, Stableforth DE, Conway SP, Littlewood JM.

BMJ. 1995 Jun 10;310(6993):1533. No abstract available.

36.

Outcome of pregnancy in women with cystic fibrosis.

Edenborough FP, Stableforth DE, Webb AK, Mackenzie WE, Smith DL.

Thorax. 1995 Feb;50(2):170-4.

37.

Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.

Lacy DE, Smith AW, Stableforth DE, Smith G, Weller PH, Brown MR.

FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):253-61.

PMID:
7539670
38.

Use of a Heimlich flutter valve for pneumothorax in cystic fibrosis.

Edenborough FP, Hussain I, Stableforth DE.

Thorax. 1994 Nov;49(11):1178-9.

39.

The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores.

Conway SP, Pond MN, Bowler I, Smith DL, Simmonds EJ, Joanes DN, Hambleton G, Hiller EJ, Stableforth DE, Weller P, et al.

Thorax. 1994 Sep;49(9):860-2. Erratum in: Thorax 1994 Nov;49(11):1184.

40.

Nocturnal hypoxaemia in cystic fibrosis: relationship to pulmonary function tests.

Smith DL, Freeman W, Cayton RM, Stableforth DE.

Respir Med. 1994 Aug;88(7):537-9. No abstract available.

PMID:
7972980
41.

Pseudomonas cepacia in cystic fibrosis.

Stableforth DE, Smith DL.

Thorax. 1994 Jul;49(7):629-30. No abstract available.

42.

Diabetes mellitus in CF patients.

Smith DL, Stableforth DE.

Br J Hosp Med. 1994 Mar 16-Apr 5;51(6):313. No abstract available.

PMID:
8080539
43.

New respiratory therapies in cystic fibrosis.

Stableforth DE.

J R Soc Med. 1994;87 Suppl 21:11-6. Review. No abstract available.

44.

Evaluation of a once-daily netilmicin regimen in the treatment of cystic fibrosis.

Smith DL, Stableforth DL, Geddes AM.

J Antimicrob Chemother. 1994 Jan;33(1):191-3. No abstract available.

PMID:
8157568
45.

A district confidential enquiry into deaths due to asthma.

Wareham NJ, Harrison BD, Jenkins PF, Nicholls J, Stableforth DE.

Thorax. 1993 Nov;48(11):1117-20.

46.

Salmonella newport in the sputum of a patient with cystic fibrosis.

Smith DL, Stableforth DE, Smith EG.

Respir Med. 1993 Nov;87(8):625-7. No abstract available.

PMID:
8290747
47.

Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL.

J Clin Microbiol. 1993 Nov;31(11):3017-22.

48.

Endurance exercise capacity in adults with cystic fibrosis.

Freeman W, Stableforth DE, Cayton RM, Morgan MD.

Respir Med. 1993 Oct;87(7):541-9.

PMID:
8265843
49.

Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping.

Smith DL, Smith EG, Gumery LB, Stableforth DE, Dalla Costa LM, Pitt TL.

J Infect. 1993 May;26(3):325-31.

PMID:
8505569
50.

Management of adults with cystic fibrosis.

Smith DL, Stableforth DE.

Br J Hosp Med. 1992 Dec 2-1993 Jan 5;48(11):713, 717-23. Review.

PMID:
1467816

Supplemental Content

Loading ...
Support Center